passaged many times in animals and in cells and acquired mutations and deletions at multiple positions during passaging (Table 1 ) [6] [7] [8] . The relevance of this strain was also questioned in a study that showed reduced toxicity and long-term persistence in human neural progenitors of an Asian-lineage ZIKV strain from Puerto Rico, which seemed more consistent with clinical manifestations [9] . Consequently, we compared the neurovirulence ex vivo of 2 low-passaged African-and Asian-lineage ZIKV strains [6] . The African ArB41644 strain was isolated in Central African Republic in 1989, whereas the Asian H/PF/2013 strain was isolated in 2013 during the French Polynesian epidemic (Table 1) . We showed that the African ZIKV strain displayed a higher infectivity and replication rate in hNSCs than the Asian ZIKV strain. ArB41644 triggered more defects in proliferation and more apoptosis, which correlated with a stronger induction of the antiviral response [6] . In a subsequent study, we compared 2 Asianlineage ZIKV strains (H/PF/2013 and ZIKVNL00013, isolated during the current epidemic in 2015) with 2 African-lineage ZIKV strains (MR766 and Uganda 927) in human neural progenitor cells and confirmed the phenotypic differences between ZIKV strains from the Asian and African lineages [10] . Both African strains infected more cells, replicated to higher titers, and induced early cell death more frequently than the Asian-lineage ZIKV strains [10] . The milder virulence of the Asian strains in these studies could be consistent with a persistent infection and effect of the Asian ZIKV lineage in developing neural cells. In addition, in dendritic cells, infection by African (MR766 and Dakar-1984) and Asian (PR-2015) strains led also to a difference in pathogenicity, as African strains triggered more cellular death [8] . Notably, this study also showed that despite differences in viral replication rates between the extensively passaged MR766 strain and the more recently isolated Dakar-1984 strain, the inductions of cell death were similar, suggesting that the ability to cause cell death seen in various cellular models with MR766 could still in certain circumstances be representative for African ZIKV lineage strains [8] .
Since infection with ZIKV strains from the Asian lineage is associated with microcephaly in humans, it is likely that ZIKV crosses the placental barrier early in gestation, when the brain is starting to develop. Some studies showed that cells of the placenta are susceptible to ZIKV infection, in line with the congenital infections and neurological symptoms associated. Because infections early in gestation seem to be more linked to microcephaly [25] , it was hypothesized that the placenta vulnerability could differ depending on the gestational stage. While the placental syncytiotrophoblast, which is found in mature placenta, appears mostly resistant to ZIKV, a study that compared an African strain (MR766) to an Asian strain (FSS13025, Cambodia) showed that embryonic stem cell (ESC)-derived trophoblasts, which recapitulate primitive placenta cells during implantation, are highly susceptible to ZIKV infection [17] . Interestingly, infection with the African strain again resulted in higher viral replication and cell lysis. These data might indicate that infection with African-lineage ZIKV strains-if they enter the fetus-could result in an early termination of pregnancy, while infection with an Asian-lineage ZIKV strain would be less destructive and more chronic, thereby allowing the pregnancy to continue, leading to the development of congenital malformations [17] .
While these ex vivo data suggested that African ZIKV lineage strains are more virulent, it was important to confirm the difference in (neuro)virulence of these 2 lineages in vivo. Interferon-α/β receptor (Ifnar) -/-mice injected subcutaneously with African ZIKV strains (MR766 and 3 strains from Senegal) or with the Asian-lineage H/PF/2013 strain all presented with weight loss and succumbed to the infection after 6 (for Senegal strains) to 10 (H/PF/2013) days. Interestingly, infection with the African-lineage strain MR766 resulted in 20% survival at 2 weeks [14] . Another study compared the symptoms induced by African (Uganda and Senegal) and Asian (Cambodia, Malaysia, and Puerto Rico) ZIKV strains in signal transducer and activator of transcription (Stat2) -/-and Ifnar -/-mice infected subcutaneously [18] . Importantly, infections with African strains resulted in more weight loss, mortality, and severe prolonged neurological symptoms compared to Asian strains. Moreover, induction of type 1 and 2 interferon (IFN) were higher following infection with African strains associated with enhanced levels of inflammatory cytokines such as interleukin 6 (IL6) or tumor necrosis factor (TNF).
These observations were confirmed in another study showing that an African strain (MP1751) is pathogenic in A129 mice, contrary to an Asian strain (PRVABC59) that did not cause signs of illness [26] . These studies confirm the ex vivo results in neural and nonneural cells regarding Asian-lineage strain led to a higher viral production as well as stronger cell death compared to the African strain.
[11]
Embryonic stem cell-derived trophoblast
African: MR766; Asian: FSS13025 African-lineage strain led to a higher viral production as well as stronger cell death compared to Asianlineage strains.
[17]
Monocyte-derived dendritic cells
African: DakAr41524, P6-740, MR766; Asian: PRVABC59 African-lineage strains led to a higher infection rate and viral production as well as stronger cell death and antiviral response compared to Asian-lineage strains.
[8]
Neuronal cell lines (SK-N-SH, U87 MG)

African: MR766, Uganda 976; Asian: H/FP/2013, ZIKVNL00013
African-lineage strains led to a higher infection rate and virus production.
[10]
In Vivo
Mosquito: Aedes aegypti
African: DAKAR41525, MR766; Asian: MEX1-7, PRVABC59, GZ01, FSS13025, H/PF/2013, BeH815744
Infection prevalence and transmission rate of African-lineage strains is higher compared to Asianlineage strains. Infection prevalence and transmission rate of Asian-lineage strains from the Americas are higher compared to Asian-lineage strains from Asia.
[ African lineage is pathogenic whereas Asian lineage does not cause sign of illness.
[23]
African-lineage strains induced higher mortality and severe neurological symptoms in a short period as compared to Asian-lineage strains.
[14]
Among Asian-lineage strains, the Cambodia strain presented more severe symptoms including front limb paralysis and lethality, followed by the Malaysia and Puerto Rico strains. The Brazilian strain is least severe. The Uganda strain showed orders of magnitude higher viral RNA level compared to all other strains including Senegal, especially in brain tissue.
[18]
Ifngr1 -/-
Higher levels of interferon type I and type II and inflammatory cytokine induction by African-lineage strains as compared to the Asian-lineage strains.
[20]
Nonhuman primate Asian: ZKV2015, PRVABC59 No differences observed [4] https://doi.org/10.1371/journal.pntd.0005821.t002 the higher virulence of African strains and could suggest that different ZIKV strains may also display phenotypic differences in human subjects (Fig 1) ( Table 2 ). Many of the findings from immunocompromised mice have been recapitulated in nonhuman primates, such as rhesus and cynomolgus macaques. The development of these different animal models led to new knowledge concerning the pathogenesis of ZIKV. However, these systems have limitations, in particular, studying viral pathogenesis using animals lacking a key component of antiviral immunity, which makes it still difficult to derive definitive conclusions regarding ZIKV virulence in humans. Therefore, many unanswered questions remain, in particular, regarding the mechanisms of host restriction, immune evasion, and inflammatory response as well as the long-term neurodevelopmental implications of congenital infection in humans. However, one major challenge in interpreting and comparing the data from these studies is the lack of harmonization of the virus strains used. In this review alone, in which we focused on studies that compared multiple ZIKV strains, at least 12 African and 13 Asian strains were found (Fig 1, Tables 1 and 2 ). While most studies include the African lineage MR766 strain, this strain cannot be considered as a standard, as it has been extensively passaged and at least 3 MR766 strains exist with genetic differences, including a 4-6 codon deletion in the envelope (E) protein [7] . For other strains, multiple sequences exist, or in some cases, no sequence data are available (Table 1) . Therefore, when comparing ZIKV lineages, the strains should be sequenced and experiments more standardized to allow proper comparison between studies. Ideally, more recent African ZIKV strains should become available (as the most recent isolate so far is from 1991) ( Table 1) .
In conclusion, the data reviewed here indicate that there are intrinsic differences in the pathogenicity/virulence of African-and Asian-lineage ZIKV strains. Whether these differences are responsible for differences in clinical presentations should be confirmed, but one can speculate that the phenotype of Asian ZIKV strains (lower infection rate, less virus production, and poor induction of early cell death) might contribute, at least in part, to the ability to cause persistent infections within the CNS of fetuses, while African-lineage ZIKV strains could result in more acute infection. However, even though ex vivo and in vivo data point towards a stronger virulence for African strains, it is still premature to conclude that if an African epidemic declares itself (due to an African ZIKV strain), neurological symptoms with similar or worse gravity than those observed in South America will be found. If confirmed, recent reports of African ZIKV strain infection and potential microcephaly in Guinea Bissau may be proof of what could be expected in this continent [27] . Determining the virulence factors for ZIKV using reverse genetic systems that have now been developed for both African and Asian strains will be crucial to identify the molecular and cellular mechanisms behind differences in ZIKV pathogenicity and also those of other emerging arboviruses.
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